PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K/AKT/mTOR signaling pathway

Huayu Hu(Guangxi University), Xiru Li(Chinese PLA General Hospital), Rui Geng(Jiangsu University), Qingyu Guan(Nankai University), Junyong Zhu(Peking University), Yashuang Ji(Integrated Chinese Medicine (China)), Yanjun Zhang(Tianjin Medical University General Hospital), Yuting Zhong(Chengdu Medical College), Aiying Qi(Chinese People's Liberation Army), Yufan Wei(Chinese PLA General Hospital), Ningning Min(Nankai University), Chenyan Hong(Nankai University)
Annals of Translational Medicine
March 1, 2021
10.21037/atm-21-698
Cited by 90

Related Papers

CA-TIMS zircon U–Pb dating of felsic ignimbrite from the Binchuan section: Implications for the termination age of Emeishan large igneous province
|Lithos|2014|258
The Guadalupian–Lopingian boundary mudstones at Chaotian (SW China) are clastic rocks rather than acidic tuffs: Implication for a temporal coincidence between the end-Guadalupian mass extinction and the Emeishan volcanism
|Lithos|2010|177
Nanopore extended field-effect transistor for selective single-molecule biosensing
|Nature Communications|2017|145
Application and outlook of topical hemostatic materials: a narrative review
|Annals of Translational Medicine|2021|122
circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma
|Molecular Therapy|2021|116